Published in Cancer Weekly, July 12th, 1999
Carol M. Bier-Laning, representing colleagues from Rhone-Poulenc Rorer, Pennsylvania, the University of Texas Southwestern Medical Center, and the University of Maryland Greenebaum Cancer Center, presented results from a phase II multi-center study of Ad5CMV-p53 in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN) at the 35th Annual Meeting of the American Society of Clinical Oncology, held May 15-18, 1999, in Atlanta, Georgia (abstract "A Phase II Multi-Center Study of Ad5CMV-p53 Administered Intratumorally to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.